{"url_path":"/sec/aytu/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1385818/0001437749-26-016721-index.html","accession_number":"0001437749-26-016721","cik":"0001385818","ticker":"AYTU","issuer_name":"AYTU BIOPHARMA, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1385818/0001437749-26-016721-index.html","primary_entity_key":"0001385818","primary_entity_name":"AYTU BIOPHARMA, INC"},"word_count":55,"has_tables":true,"body_markdown":"**ITEM 5. OTHER INFORMATION**\n\n \n\n**Rule 10b5-1 Trading Plans**\n\n \n\nDuring the quarter ended *March 31, 2026*, none of our directors or executive officers (as defined in Rule *16a*-*1* under the Exchange Act) adopted or terminated a “Rule *10b5*-*1* trading arrangement” or “non-Rule *10b5*-*1* trading arrangement” (as those terms are defined in Item *408* of Regulation S-K)."}